Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elisabeth Prevete has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Emerging poisoning trends on social media: Sodium nitrite and nitrate content on TikTok

    by Ornella Corazza, Sulaf Assi, Elisabeth Prevete, Sofia Venturini, Dhiya Al-Jumeily Obe, Sam Selek

  • Open Access

    Forms of interventions for problematic usage of the internet: A scoping review

    by Irene P. Carvalho, Artemisa R. Dores, Ilaria Cataldo, Valeria Catalani, Luca Pellegrini, Elisabeth Prevete, Natalie Hall, Thomas Zandonai, Andres Roman-Urrestarazu, Julius Burkauskas, et al.

    Background and aims: This scoping review aims to identify current forms of interventions for Problematic Usage of the Internet (PUI) to inform more effective intervention and policy-making initiatives grounded in robust empirical evidence. Methods: The search was conducted in the PubMed, Scopus, and PsycINFO databases until October 12, 2024. Empirical research presenting data on interventions for PUI and written in English was included without restrictions of age groups, types of interventions, or types of PUI. Results: Five main forms of interventions for PUI were identified in the 77 studies included in the review, namely, pharmacotherapy, transcranial direct current stimulation, physical exercise, electroacupuncture, and psychotherapy or educational programs. Most studies were conducted in Asian and Middle-Eastern countries, and various validated instruments were used to assess PUI. Psychotherapy and education were the most common interventions in research. Apart from time spent online, positive results of the various interventions were reported on the respective PUI scales in most studies. However, studies with rigorous designs showed non-significant changes, suggesting that methodological differences may influence the reported outcomes. Discussion and conclusions: The different interventions reflect the multidimensional nature and complexity of PUI treatment and prevention strategies. Although current interventions show potential, more robust and rigorous study designs are necessary to draw definite conclusions. Further investigation is needed to understand the influence of comorbidities and the impact of individuals actively seeking help on treatment outcomes. Additionally, more substantial evidence is required to evaluate the effectiveness of PUI prevention efforts, particularly considering varying levels of PUI severity.


  • Open Access

    Use patterns of classic, novel, and herbal opioids

    by Elisabeth Prevete, Natasha L. Mason, Kim P. C. Kuypers, Eef L. Theunissen, Pablo Mallaroni, Massimo Pasquini, Johannes G. Ramaekers


  • Schizophrenia and Other Late-Life Psychoses

    by Francesco Saverio Bersani, Elisabeth Prevete, Roberto Vicinanza

  • Schizophrenia and Other Late-Life Psychoses

    by Francesco Saverio Bersani, Elisabeth Prevete, Roberto Vicinanza

  • A Preliminary Inventory of Kratom (Mitragyna Speciosa) Products and Vendors on the Darknet and Cryptomarkets

    by Elisabeth Prevete, Valeria Catalani, Darshan Singh, Kim P. C. Kuypers, Eef L. Theunissen, Honor D. Townshend, Hani Banayoti, Johannes G. Ramaekers, Massimo Pasquini, Ornella Corazza

    In recent years, the online sale of kratom (Mitragyna speciosa), a Southeast Asian plant with both medicinal and psychoactive properties, has raised health concerns mainly due to the uncontrolled diffusion of adulterated kratom-related products. This exploratory study provides, for the first time, a snapshot of the availability of kratom products on the darknet which has been further validated by data searches on the surface web. A total of 231 listings of kratom across 23 darknet marketplaces were identified between March 2020 and October 2021. Among these, 40 were found actively sold across five markets by thirteen vendors. Listed items were mainly advertised as "safe" substitutes for medicinal products for the self-management of pain and other health conditions and offered in various forms (e.g., dry leaf powder, pills, capsules). Purchases were made using cryptocurrencies, with some vendors offering Pretty Good Privacy, and were shipped from Europe, Australia, the United States, and the United Kingdom. Goods sold by the same sellers also included illicit drugs and fraud-related products. Our study discovered a previously unknown diffusion of kratom products on the darknet mainly for self-treating a variety of medical conditions, suggesting the need for further research and immediate interventions to safeguard the well-being and health of kratom consumers.


  • Open Access

    Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review

    by Elisabeth Prevete, Kim Paula Colette Kuypers, Eef Lien Theunissen, Gianluca Esposito, Johannes Gerardus Ramaekers, Massimo Pasquini, Ornella Corazza

    : Purpose of Review: This work aims to provide an up-to-date review of the preclinical and clinical scientific literature on the therapeutic value of kratom to better understand the underlying mechanisms related to its use and inform future therapeutic applications.Recent Findings: A growing number of studies, mainly of cross-sectional nature, describe the widespread use of kratom by individuals to self-treat pain, psychiatric symptoms, and substance use disorders (SUD) outside a controlled clinical setting. Preclinical evidence suggests kratom is effective as an analgesic agent and might decrease the self-administration of other drugs. A randomized controlled trial has further supported kratom’s therapeutic value as an analgesic. Investigations in nonclinical samples of long-term kratom users also indicate its therapeutic benefit in managing SUD symptoms (e.g., craving) and long-term or acute symptoms (e.g., withdrawal) for alcohol, opioids, and other illicit drugs. However, episodes of kratom-related intoxications have also been reported, often due to the adulteration and the contamination of kratom products mainly sold online or mixed toxicities when consumed outside clinical and traditional settings.Summary: Evidence on the clinical implications of kratom use is still limited and uncertain, with kratom research constantly evolving. Therefore, further randomized trials are needed.


  • Open Access

    Problematic Use of the Internet Mediates the Association between Reduced Mentalization and Suicidal Ideation: A Cross-Sectional Study in Young Adults

    by Francesco Saverio Bersani, Tommaso Accinni, Giuseppe Alessio Carbone, Ornella Corazza, Angelo Panno, Elisabeth Prevete, Laura Bernabei, Chiara Massullo, Julius Burkauskas, Lorenzo Tarsitani, et al.

    Suicide is a major public health problem, and it is urgent to investigate its underlying clinical and psychological concomitants. It has been suggested that low mentalization skills and problematic use of the internet (PUI) are factors that can play a role in suicidal behaviors. It is possible that poor mentalization skills contribute to leading to forms of PUI, which, in turn, can represent triggers for suicidal ideation (SI). We tested this hypothesis through a quantitative and cross-sectional study on a sample (n = 623) of young adults (age range: 18–34). Self-report measures investigating symptoms related to Social Media Addiction (SMA), Internet Gaming Disorder (IGD), mentalization capacity, and SI were used. A single mediation analysis with two mediators was carried out to evaluate the direct and indirect effects of mentalization on SI through the mediating role of SMA- and IGD-related symptoms, controlling for potential confounding factors (e.g., socio-demographic and addiction-related variables). The four explored variables were significantly associated with each other (all p < 0.001) across all subjects; the mediational model showed that the total effect of mentalization on SI was significant (B = −0.821, SE = 0.092 (95% CI: −1.001; −0.641)) and that both SMA- (B = −0.073, SE = 0.034 (95% CI: −0.145; −0.008)) and IGD-related symptoms (B = 0.046, SE = 0.027 (95% CI: −0.107; −0.001)) were significant mediators of such association. Our findings support the possibility that PUI severity plays a relevant role in mediating the association between low mentalization skills and levels of SI.


  • Open Access

    A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab

    by Nicoletta Bernardini, Nevena Skroza, Federica Marraffa, Elisabeth Prevete, Alessandra Mambrin, Ilaria Proietti, Ersilia Tolino, Martina Caviglia, Antonio Di Guardo, Giovanni Rossi, et al.


  • Open Access

    A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans

    by Elisabeth Prevete, Kim Paula Colette Kuypers, Eef Lien Theunissen, Ornella Corazza, Giuseppe Bersani, Johannes Gerardus Ramaekers

    Introduction: Kratom (Mitragyna speciosa) is a tropical plant traditionally used as an ethnomedicinal remedy for several conditions in South East Asia. Despite the increased interest in its therapeutical benefits in Western countries, little scientific evidence is available to support such claims, and existing data remain limited to kratom's chronic consumption.Objective: Our study aims to investigate (pre)clinical evidence on the efficacy of kratom as a therapeutic aid and its safety profile in humans.Methods: A systematic literature search using PubMed and the Medline database was conducted between April and November 2020.Results: Both preclinical (N = 57) and clinical (N = 18) studies emerged from our search. Preclinical data indicated a therapeutic value in terms of acute/chronic pain (N = 23), morphine/ethanol withdrawal, and dependence (N = 14), among other medical conditions (N = 26). Clinical data included interventional studies (N = 2) reporting reduced pain sensitivity, and observational studies (N = 9) describing the association between kratom's chronic (daily/frequent) use and safety issues, in terms of health consequences (e.g., learning impairment, high cholesterol level, dependence/withdrawal).Conclusions: Although the initial (pre)clinical evidence on kratom's therapeutic potential and its safety profile in humans is encouraging, further validation in large, controlled clinical trials is required.